C-ARCH

V:ARCH - Arch Biopartners Inc. - http://www.archbiopartners.com

10:25:32 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
ARCH - V	1.4	1.77	·	1.80	0.2	1.77	+0.01	0.6	70.1	115	234	1.78 1.90 1.76	2.56 0.97	15:59:14	Apr 16	15 min RT 2¢
TSX-V - V	1.4	1.77	·	1.80	0.2	1.77	+0.01	0.6	49.6	81	173	1.78 1.90 1.76	2.56 0.97	15:59:14		15 min
NEO ATS - U						1.78	+0.02	1.1	0.2	0	2	1.78 1.78 1.78		09:45:29		15 min
Alpha - A						1.81	+0.05	2.8	9.4	17	8	1.89 1.89 1.79		15:05:29		15 min
Omega - O						1.77	+0.01	0.6	4.2	6	17	1.85 1.89 1.77		15:35:24		15 min
CX2 - H						1.77	+0.01	0.6	5.0	8	19	1.77 1.88 1.77		15:35:24		15 min
CXD - D						1.78	+0.02	1.1	0.5	1	7	1.87 1.87 1.78		14:23:06		15 min
TriAct - M						1.76			1.2	2	8			Sep 11-20		15 min

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
NOTE: Delayed ATS trade data is included - click System Status for more information

Show ATS · Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · Company · Participants · 1yr Bulletins · Sedar · Historical · Shorts · Portfolio

Recent Trades - Last 10 of 234

More trades...

Time ET	Ex	Price	Change	Volume	Buyer	Seller	Markers
15:59:14	V	1.77	0.01	300	98 Red Cloud	1 Anonymous	K
15:59:14	V	1.77	0.01	300	9 BMO Nesbitt	1 Anonymous	K
15:58:36	V	1.77	0.01	2	2 RBC	1 Anonymous
15:55:34	V	1.77	0.01	300	98 Red Cloud	33 Canaccord	K
15:55:34	V	1.77	0.01	300	84 ITG84	33 Canaccord	K
15:42:10	V	1.78	0.02	700	98 Red Cloud	1 Anonymous	K
15:41:22	V	1.78	0.02	300	98 Red Cloud	1 Anonymous	K
15:36:22	V	1.78	0.02	300	98 Red Cloud	80 National Bank	K
15:36:16	V	1.78	0.02	200	98 Red Cloud	1 Anonymous	K
15:36:16	V	1.79	0.03	100	98 Red Cloud	79 CIBC	K

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Price	Type	Headline
2024-04-16 11:51	C:ARCH	2.38	News Release200	Arch adds St. Michael's Hospital to LSALT trial
2024-04-03 10:26	C:ARCH	2.39	News Release200	Arch Biopartners welcomes UHN to LSALT phase II
2024-04-02 11:18	C:ARCH	2.30	News Release200	Arch Biopartners adds 3 sites to phase 2 LSALT trial
2024-03-18 10:41	C:ARCH	2.20	News Release200	Arch publishes phase II LSALT trial data in BMJ Open
2024-03-15 10:10	C:ARCH	2.20	News Release200	Arch adds University of Calgary to LSALT trial
2024-03-07 10:24	C:ARCH	1.56	News Release200	Arch doses 1st patient in phase II LSALT peptide trial
2024-02-27 12:03	C:ARCH	1.60	News Release200	Arch Biopartners completes pre-IND meeting with FDA
2024-01-10 08:45	C:ARCH	1.44	News Release200	Arch Biopartners okayed for phase 2 LSALT peptide trial
2024-01-03 10:32	C:ARCH	1.45	News Release200	Arch receives Turkish MoH OK for phase II LSALT trial
2023-12-21 11:04	C:ARCH	1.50	News Release200	Arch Biopartners receives Turkish LSALT phase II ok
2023-12-18 11:05	C:ARCH	1.45	News Release200	Arch Biopartners grants options to buy 350,000 shares
2023-12-13 11:08	C:ARCH	1.44	News Release200	Arch Biopartners applies for phase II LSALT trial
2023-11-09 16:34	C:ARCH	1.02	Shares for Debt330	Arch Biopartners 156,818 shares for debt
2023-10-24 12:58	C:ARCH	1.09	News Release200	Arch to settle $172,500 interest with shares
2023-09-22 09:21	C:ARCH	1.45	News Release200	Arch applies for LSALT peptide phase II trial in Turkey
2023-07-31 18:20	C:ARCH	2.07	News Release200	Arch Biopartners hires ITG as market-maker
2023-06-27 10:42	C:ARCH	2.14	News Release200	Arch Biopartners to proceed with phase 2 LSALT trial

Date ET

Symbol

Price

Type

Headline

2024-04-16 11:51

C:ARCH

2.38

News Release

Arch adds St. Michael's Hospital to LSALT trial

2024-04-03 10:26

C:ARCH